FDA Inspection 1237140 — Fresenius Kabi Warrendale

Fresenius Kabi Warrendale — FEI 3005778453

The FDA completed an inspection of Fresenius Kabi Warrendale on April 16, 2024 in Warrendale, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 16, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Warrendale, PA (United States)